Pre-upgrade fulminations

Have a laugh. A sarcastic laugh, maybe, but still… In yesterday’s comments I mentioned that the administration appears to be putting ideology ahead of scientific experience in its FDA appointments; that’s not just my opinion. More examples of administration obstructionism: now it seemingly objects to the makeup of an independent panel designed to investigate September …

Continue reading ‘Pre-upgrade fulminations’ »